Disease

Diplomatic Reception Room

October 30, 2009 -- THE PRESIDENT: Good morning, everybody.

AUDIENCE: Good morning.

THE PRESIDENT: We often speak about AIDS as if it's going on somewhere else. And for good reason -- this is a virus that has touched lives and decimated communities around the world, particularly in Africa. But often overlooked is the fact that we face a serious HIV/AIDS epidemic of our own -- right here in Washington, D.C., and right here in the United States of America. And today, we are taking two important steps forward in the fight that we face here at home.    » read more »

November 2, 2009 -- Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.

“For pregnant women, who are among the most vulnerable to serious health problems from 2009 H1N1 infection, these initial results are very reassuring,” says NIAID Director Anthony S. Fauci, M.D. “The immune responses seen in these healthy pregnant women are comparable to those seen in healthy adults at the same time point after a single vaccination, and the vaccine has been well tolerated.”    » read more »

WASHINGTON, Nov. 3, 2009 – Like protective equipment issued to troops downrange, the H1N1 flu vaccine is a measure the Defense Department is taking to safeguard U.S. military forces, a defense official said today.

“We use other treatment modalities to protect people in the same way we use body armor to protect against other threats,” said Ellen P. Embrey, acting assistant secretary of defense for health affairs.

“The H1N1 vaccine was purchased specifically for our uniformed servicemembers so they could continue to perform their mission anywhere on the globe,” she continued. “And during a pandemic, that’s a real threat.”    » read more »

Nov 02, 2009 -- WASHINGTON — As shipments of some 3.7 million doses of H1N1 vaccine ordered by the Defense Department continue to arrive from the manufacturer, more than enough will be available for all military personnel and their beneficiaries, military medical experts say.

Navy Cmdr. Danny Shiau, division chief for the Bureau of Navy Medicine and Surgery's force health protection, and Dr. Robert Morrow, the bureau's preventive medicine programs and policy officer, took questions about the military's seasonal flu and H1N1 preparedness efforts during an Oct. 29 "DoDLive" bloggers roundtable.

Morrow explained why it has taken the primary manufacturer, Novartis, longer than expected to produce the vaccine.    » read more »

Washington, DC - 10/30/2009 - A survey of state health departments regarding their capacity to track produce-related foodborne illnesses found that the response and investigation of outbreaks varies greatly and can lead to delays in public-health response.

The survey was commissioned by the Produce Safety Project (PSP), an initiative of The Pew Charitable Trusts at Georgetown University, and conducted by Safe Tables Our Priority (S.T.O.P.). Thirty-nine of the 51 state and District of Columbia health departments responded to the survey, which asked about the types of questions and questionnaires administered to victims of foodborne illness, the time frame in which they were completed, and how states collected and stored the resulting data for calendar year 2007.    » read more »

October 30, 2009 -- As cases of H1N1 continue to mount in Connecticut, Governor M. Jodi Rell today has asked the state Department of Public Health for an inventory of anti-viral medication in Connecticut and is urging federal health officials to immediately release a second round of anti-viral medication from the Strategic National Stockpile (SNS).

This development comes the same day the Centers for Disease Control and Prevention (CDC) raised Connecticut’s flu activity classification to “widespread,” the highest level of activity.    » read more »

Pivotal testing of RTS,S is on track for target enrollment of 16,000 children

NAIROBI, KENYA November 3, 2009 -- A pivotal efficacy trial of RTS,S, the world’s most clinically advanced malaria vaccine candidate, is now underway in seven African countries: Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania. The trial, which is expected to involve up to 16,000 children, is on schedule, with more than 5,000 children already enrolled, researchers announced Tuesday at the 5th Multilateral Initiative on Malaria Pan-African Malaria Conference.    » read more »

Sequence will Spur Advancements in Swine Production and Human Medicine

WASHINGTON, Nov. 2, 2009 - An international team of scientists, funded with a $10 million grant from the National Institute of Food and Agriculture (NIFA), has completed the first draft of the genome of a domesticated pig. This first draft sequence will spur advancements in swine production and human medicine.

"Understanding the swine genome will lead to health advancements in the swine population and accelerate the development of vaccinations for pigs," said Roger Beachy, NIFA director. "This new insight into the genetic makeup of the swine population can help reduce disease and enable medical advancements in both pigs and humans."    » read more »

"Saves Lives and Offers a Lifeline of Treatment and Support to Americans Living With HIV/AIDS"

October 30, 2009 -- Washington, D.C. -- Speaker Nancy Pelosi issued the following statement today after attending a ceremony at the White House where President Obama signed the Ryan White HIV/AIDS Treatment Extension Act into law.    » read more »

Calls on DOL to Improve the Claims Process for Coal Miners

October 30, 2009 -- Washington, D.C. -- Senator Jay Rockefeller today released a report he requested from the Government Accountability Office (GAO) regarding the persistent barriers that miners and their families face when trying to secure benefits through the federal Black Lung Benefits Program. Senator Rockefeller called on the U.S. Department of Labor (DOL) to quickly consider and act on the report and he plans to introduce related legislation.    » read more »

Bill Clears Congress Late Thursday, President Will Sign

WASHINGTON -- Oct. 29 -- The U.S. Senate Thursday night passed a bill that includes emergency help authored by U.S. Senator Patrick Leahy (D-Vt.) to address a disease that is decimating bat populations in Vermont and the Northeast.

Leahy secured $1.9 million to buttress the U.S. Fish and Wildlife Service’s response to the puzzling outbreak of “white nose syndrome” in Northeast bat populations. Leahy’s provision, in the annual budget bill for the Department of the Interior and other agencies, doubles funding for investigating and devising solutions to the epidemic. Leahy is a senior member of the Senate Appropriations Committee and a conferee on the Interior Appropriations Bill.    » read more »

Testimony of Alex Garza, MD,MPH, Office of Health Affairs; Richard Serino,FEMA; Marcy Forman, ICE before U.S. House of Representatives, Committee on Homeland Security Subcommittee on Emerging Threats,Cybersecurity and Science & Technology on "Real-Time Assessment of the Federal Response to Pandemic"

October 27, 2009 -- Cannon House Office Building -- (Written Testimony)    » read more »

Agriculture Secretary Vilsack: "U.S. Pork Is Safe to Eat"

WASHINGTON, Oct. 19, 2009 - Agriculture Secretary Tom Vilsack today announced that USDA's National Veterinary Services Laboratories (NVSL) has confirmed the presence of 2009 pandemic H1N1 influenza virus in a pig sample collected at the Minnesota State Fair submitted by the University of Minnesota. Additional samples are being tested.

"We have fully engaged our trading partners to remind them that several international organizations, including the World Organization for Animal Health, have advised that there is no scientific basis to restrict trade in pork and pork products," said Vilsack. "People cannot get this flu from eating pork or pork products. Pork is safe to eat."    » read more »

Findings by Scripps Research Scientists Brighten Prospects of Stem Cell Therapy for Range of Diseases

LA JOLLA, CA – October 15, 2009 A team led by scientists from The Scripps Research Institute has developed a method that dramatically improves the efficiency of creating stem cells from human adult tissue, without the use of embryonic cells. The research makes great strides in addressing a major practical challenge in the development of stem-cell-based medicine.

The findings were published in an advance, online issue of the journal Nature Methods on October 18, 2009.    » read more »

10/19/09 -- WASHINGTON, D.C. — U.S. Rep. Zack Space (OH-18) today applauded the U.S. Department of Veterans Affairs for their decision to fast track the application process for Vietnam veterans suffering from Parkinson’s disease, B-cell leukemia, or ischemic heart disease as a result of exposure to Agent Orange.

“This is the right decision for veterans across Ohio and the nation,” Space said. “It will expand access to medical care for millions of our men and women who served in uniform, and it will provide many of our veterans long overdue care for the conditions contracted as a result of their service. “    » read more »